Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
Frazer, Ian H., Quinn, Michael, Nicklin, Jim L., Tan, Jeffrey, Perrin, Lew C., Ng, Peng, O’Connor, Vivienne M., White, Olivia, Wendt, Ngaire, Martin, Juliet, Crowley, Jayne M., Edwards, Stirling J., McKenzie, Andrew W., Mitchell, Susan V., Maher, Darryl W., Pearse, Martin J., Basser, Russell L.
Published in Vaccine (25.11.2004)
Published in Vaccine (25.11.2004)
Get full text
Journal Article